Paper9719484
The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells.
Grech KV and 2 others. Biochem Pharmacol, 1998. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells. Papers, record 9719484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9719484
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP-Binding Cassette Transporters | Major topic |
| Drug Resistance, Multiple | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Glutathione | Major topic |
| Antineoplastic Agents | |
| Buthionine Sulfoximine | |
| Cell Division | |
| Daunorubicin | |
| Etoposide | |
| Gene Expression Regulation, Neoplastic | |
| Genes, MDR | |
| Humans | |
| Leukemia | |
| ATP-Binding Cassette, Sub-Family C Proteins | |
| Tumor Cells, Cultured |
Source PubMed
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28050891 | A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells. | Drug Deliv Transl Res | 2017 | https://conductscience.org/library/papers/28050891 | PubMed |
| 17585883 | Harnessing drug resistance: using ABC transporter proteins to target cancer cells. | Biochem Pharmacol | 2007 | https://conductscience.org/library/papers/17585883 | PubMed |
| 17549417 | Selected flavonoids potentiate the toxicity of cisplatin in human lung adenocarcinoma cells: a role for glutathione depletion. | Int J Oncol | 2007 | https://conductscience.org/library/papers/17549417 | PubMed |
| 12466237 | The use of Tris-lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1. | Br J Pharmacol | 2002 | https://conductscience.org/library/papers/12466237 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| ABCC1 | 4363 | PubTator's text mining | https://conductscience.org/library/genes/4363 | NCBI Gene |
| ABCC3 | 8714 | PubTator's text mining | https://conductscience.org/library/genes/8714 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9719484
GET https://conductscience.org/api/papers/v1/9719484/authors